Catalyst Biosciences Inc Shares Approach 52-Week Low - Market Mover
The shares closed 0.8% above its 52-week low of $1.24, with trading volume higher than its 30 day average
Nov 27, 2021 by Kwhen Finance Editors
Catalyst Biosciences Inc (CBIO) shares closed today at 0.8% above its 52 week low of $1.24, giving the company a market cap of $39M. The stock is currently down 80.2% year-to-date, down 78.4% over the past 12 months, and down 89.5% over the past five years. This week, the Dow Jones Industrial Average fell 1.9%, and the S&P 500 fell 2.1%.
Trading Activity
- Trading volume this week was 19.7% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Catalyst Biosciences Inc | -7.4 | -80.2 | -78.4 | -82.4 | 7.3 |
| Dow Jones Industrial Average | -2.5 | 15.9 | 18.8 | -4.0 | 20.9 |
| S&P 500 Index | -2.2 | 24.0 | 28.3 | -2.3 | 30.6 |
| Health Care | -0.5 | 16.2 | 22.5 | -3.2 | 22.6 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 720.7%
- The company's stock price performance over the past 12 months lags the peer average by 588.8%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Catalyst Biosciences Inc | CBIO | -0.5 | -80.2 | -78.4 | -82.4 | 7.3 |
| Peer Avg | N/A | 4.5 | -9.8 | -11.4 | -19.9 | 6.8 |
| National Research Corp | NRC | 29.1 | -2.8 | -22.3 | -23.7 | 3.8 |
| Nymox Pharmaceutical Corp | NYMX | -11.3 | -36.3 | -23.3 | -56.0 | 23.2 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: